Patent ID: 7235238

Claim:
A pharmaceutical composition comprising a suitable diluent or carrier and an antigen-binding fragment of an antibody that binds a polypeptide selected from the group consisting of: a) a polypeptide consisting of amino acids −19 to 522 of SEQ ID NO:2; b) a polypeptide consisting of amino acids 1 to 522 of SEQ ID NO:2; c) a polypeptide consisting of amino acids −19 to 310 of SEQ ID NO:2; d) a polypeptide consisting of amino acids 1 to 310 of SEQ ID NO:2; e) a polypeptide consisting of amino acids 1 to 310 or SEQ ID NO:2, with the proviso that the polypeptide lacks the residue at position 298 of SEQ ID NO:2; f) a polypeptide consisting of amino acids 1 to 522 of SEQ ID NO:2 with the proviso that the polypeptide lacks the residue at position 298 of SEQ ID NO:2; g) a polypeptide consisting of amino acids −19 to 310 of SEQ ID NO:2, with the proviso that the polypeptide lacks the residue at position 298 of SEQ ID NO:2; and h) a polypeptide consisting of amino acids −19 to 522 of SEQ ID NO:2, with the proviso that the polypeptide lacks the residue at position 298 of SEQ ID NO:2.